Bicara Therapeutics Inc Common Stock
Quarterly Financials
| Values in thousands | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
Gross Profit | -19 | -19 | -15 | -15 |
EBITDA | -32,018 | -41,788 | -26,622 | -20,613 |
EBIT | -41,807 | -26,637 | -20,628 | |
Net Income | -27,388 | -36,846 | -20,957 | -17,481 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Free Cash Flow | -25,594 | -28,106 | -30,072 | -17,232 |
Cash | 436,606 | 462,065 | 489,711 | 520,758 |
Basic Shares | 54,539 | 54,456 | 54,440 | 54,409 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|
Revenue | $0 | $0 | $0 |
Gross Profit | -56 | -19 | -10 |
EBITDA | -67,752 | -51,961 | -37,722 |
EBIT | -67,808 | -51,980 | -37,732 |
Net Income | -67,995 | -51,985 | -37,845 |
Net Change In Cash | 0 | 0 | 0 |
Free Cash Flow | -74,822 | -46,214 | -32,268 |
Cash | 489,711 | 230,440 | 4,158 |
Basic Shares | 54,424 | 51,760 | 51,760 |
Earnings Calls
| Quarter | EPS |
|---|---|
2025-09-30 | $0 |
2025-06-30 | -$0.50 |
2025-03-31 | -$0.68 |
2024-12-31 | -$0.39 |
